FERG.UK

12,010

-4.15%↓

FERG.UK

12,010

-4.15%↓

FERG.UK

12,010

-4.15%↓

FERG.UK

12,010

-4.15%↓

FERG.UK

12,010

-4.15%↓

Search

ConvaTec Group PLC

Fermé

SecteurFinance

258.2 0.39

Résumé

Variation du prix de l'action

24h

Actuel

Min

253.8

Max

263

Chiffres clés

By Trading Economics

Revenu

79M

Ventes

1.1B

P/E

Moyenne du Secteur

36.743

22.015

BPA

0.07

Rendement du dividende

1.96

Marge bénéficiaire

7.059

Employés

10,489

EBITDA

251M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+21.8% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.96%

3.90%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

203M

5.3B

Ouverture précédente

257.81

Clôture précédente

258.2

Sentiment de l'Actualité

By Acuity

50%

50%

223 / 542 Classement par Finance

ConvaTec Group PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

26 févr. 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Comparaison

Variation de prix

ConvaTec Group PLC prévision

Objectif de Prix

By TipRanks

21.8% hausse

Prévisions sur 12 Mois

Moyen 314.25 GBX  21.8%

Haut 375 GBX

Bas 282 GBX

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

8 ratings

8

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

223 / 542Classement par Finance

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.